Tutssels Enterprise IG has designed the website for GlaxoSmithKline skin treatment brand Eumovate, to support the brand’s move from prescription-only to over-the counter availability.
The project, which launched last week, follows Tutssels revamp of the identity and packaging for the brand in January, and is worth a six-figure sum to the consultancy.
Tutssels Enterprise IG is also working on other Eumovate brand communications materials, but refuses to disclose further details about the work.
The website, www.skinflare-up.com, will act as an e-commerce site and offer advice to sufferers of eczema and dermatitis, which Eumovate helps to treat.
The website is endorsed by the National Eczema Society and a leading dermatologist and has links to a pharmacy brand for the purposes of e-commerce.
The site will eventually be translated into a variety of languages with a view to launching it globally.
‘We were asked to present a strategy for how to use e-marketing in its broadest sense to support the switch to over-the-counter status,’ says Tutssels Enterprise IG director Beverley Law.
‘The site will raise awareness of the brand and of eczema and dermatitis. It will also ensure that people use Eumovate correctly. The site will continue to evolve and support sufferers,’ she adds.
Tuttsels Enterprise IG design director of new media Tristan Fawley says, ‘New media enables us to simplify a previously misunderstood and misdiagnosed category.’
The site features a four-step process that claims to establish whether the user is suffering from ‘skin flare-up’ and directs them to seek further advice if they are not. It also uses diagrams and body images to show how the body reacts to things that trigger a reaction on the skin.
The consultancy won a two-way strategic and creative pitch to secure the work. It has worked with SmithKline Beecham since 1992 and Glaxo Wellcome since 1999, and is retained by the merged company GSK.
GSK has launched a consumer awareness campaign about eczema and dermatitis with above-the-line advertising.